Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients.

Tytuł :
Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients.
Autorzy :
Yamamoto, Ana Maria
Gajdos, Philippe
Eymard, Bruno
Tranchant, Christine
Warter, Jean-Marie
Gomez, Lucienne
Bourquin, Charles
Bach, Jean-François
Garchon, Henri-Jean
Pokaż więcej
Temat :
MYASTHENIA gravis
ANTIGENS
IMMUNOGLOBULINS
Źródło :
Archives of Neurology; Jun2001, Vol. 58 Issue 6, p885, 6p
Czasopismo naukowe
Background: Titin is the major autoantigen recognized by anti–striated muscle antibodies, which are characteristic of generalized myasthenia gravis (MG). Objective: To seek a correlation between anti-titin antibodies and other features of MG patients, including histopathology, age at diagnosis, anti–acetylcholine receptor (anti-AChR), autoantibody titers, and clinical severity. Methods: A novel, highly specific radioligand assay was performed on a large group of 398 patients with generalized MG. Results: Among thymectomized patients, anti-titin antibodies were present in most patients with thymoma (56/70 [80%]), contrasting with only a minority of patients with thymus atrophy or hyperplasia (17/165 [10%]). They were also present in 64 (41%) of 155 nonthymectomized patients who had a radiologically normal thymus. In these patients and in those who had a histologically normal thymus, anti-titin antibodies were associated with a later age at onset of disease and with intermediate titers of anti-AChR antibodies. After controlling for these 2 variables, disease severity was not significantly influenced by anti-titin antibodies. Conclusions: Anti-titin antibodies are a sensitive marker of thymoma associated with MG in patients 60 years and younger, justifying the insistent search for a thymoma in MG patients of this age group who have these antibodies. In nonthymoma patients, anti-titin antibodies represent an interesting marker complementary to the anti-AChR antibody titer, identifying a restricted subset of patients. These clinical correlations should prompt further studies to examine the mechanisms leading to the production of anti-titin antibodies. [ABSTRACT FROM AUTHOR]
Copyright of Archives of Neurology is the property of American Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies